What service do you need? Contact Request

NCT06473701

Reducing Breathlessness With Dronabinol in COPD Patients

← Clinical trials hub

Registry fields

Overall status: COMPLETED
Conditions: COPD, Breathlessness, Cannabis
Study type: INTERVENTIONAL
Phase: PHASE3
Primary purpose: SUPPORTIVE_CARE
Intervention type: DRUG
Interventions: Dronabinol 2.5mg Capsule, Placebo
Lead sponsor: Vejle Hospital (OTHER)

Cached at: 2026-10-06 06:52:30

View on ClinicalTrials.gov

Brief summary

This clinical trial examines whether Dronabinol, which contains the synthetic psychoactive compound tetrahydrocannabinol (THC), can alleviate severe breathlessness in patients with severe and very severe chronic obstructive pulmonary disease (COPD).

Contact

Need a report or Korean medical writing based on this trial?

Request a report Medical writing Custom research report